<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 08-Aug-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (08-Aug-2025)</h1>
<h2>Key News Highlights</h2>
<ul>
<li><strong>US Tariffs &amp; Trade Tensions</strong>: Trump administration implements broad, steep new tariffs. Major trading partners (EU, China, Canada, Mexico, South Korea, Japan, Taiwan, India) heavily impacted. Consumer price increases flagged.</li>
<li><strong>Interest Rate Policy</strong>: Trump set to nominate economic advisor to vacant Fed board seat. No FOMC rate hikes expected near-term.</li>
<li><strong>401(k) Investment Options</strong>: New executive order now allows private equity, crypto, and real estate in 401(k) plans.</li>
<li><strong>Russia/Ukraine &amp; Geopolitics</strong>: Putin suggests UAE summit with Trump; Ukraine ceasefire unlikely this year.</li>
<li><strong>Domestic Politics</strong>: FBI leadership ousters and DC security headlines signal ongoing governmental and institutional churn.</li>
<li><strong>Tech &amp; AI</strong>: OpenAI releases ChatGPT-5; Microsoft rapidly integrates latest gen AI into product suite.</li>
<li><strong>Energy Markets</strong>: Pressure remains on oil prices driven by Russian supplies and heightened trade friction, but no evidence yet of breakthrough on US climate goals.</li>
<li><strong>Healthcare/Science</strong>: Federal mRNA vaccine funding cuts spark global concern. New lithium studies ignite Alzheimer’s research optimism.</li>
<li><strong>Corporate/Entertainment</strong>: Paramount completes merger, Disney settles with Gina Carano.</li>
</ul>
<hr />
<h2>Macro &amp; Market Environment</h2>
<h3>US Macroeconomics &amp; Policy</h3>
<ul>
<li><strong>Growth &amp; Inflation</strong>: Consensus expects US GDP growth to be modest (between 1.1-2.5%), with inflation running above historical averages but not extreme. Core CPI likely to remain sticky at mid-2%–4% range.</li>
<li><strong>Rate Outlook</strong>: The Fed is not anticipated to hike further in 2025. By late 2026, rates are likely to settle between 3–3.5%, with no major hawkish surprises projected. Government spending continues to grow, and the deficit is not meaningfully shrinking.</li>
<li><strong>Fiscal Policy &amp; Debt</strong>: US debt set to surpass $38T by year-end, continuing structural upward pressure on yields. Policy focus remains stimulative, with increased outlays and deficit spending.</li>
<li><strong>Labor Market</strong>: Unemployment remains relatively low short-term, but higher levels (above 4%) are increasingly likely over the next few months. Tech sector layoffs are rising in 2025, possibly pushing headline metrics above 4.1% before autumn. Despite headline layoffs, wage growth is expected to keep up with or exceed current inflation.</li>
</ul>
<h3>Global Macro</h3>
<ul>
<li><strong>Trade &amp; Currency</strong>: The USD is weakening, with the dollar index at risk of dropping below multi-year technical supports. New and higher tariffs on a wide array of major economic partners will impact US trade balances and are likely inflationary on net. India faces targeted US tariffs unless a resolution is reached imminently.</li>
<li><strong>Geopolitical Risks</strong>: No immediate Russia-Ukraine ceasefire anticipated. Israel/Gaza tensions remain high. G7 political churn is concentrated in Japan with leadership transition likely; minor implications for JPY volatility.</li>
<li><strong>China/EM</strong>: China is not viewed as likely to surpass the US in GDP by 2030. However, ongoing trade and currency friction remains a medium-term risk for EM and global supply chains.</li>
</ul>
<hr />
<h2>Sector Implications</h2>
<h3>Technology &amp; Semiconductors</h3>
<ul>
<li><strong>AI Advancements</strong>: OpenAI's launch of GPT-5 and assimilation into Microsoft's offerings further entrenches the AI/Big Tech duopoly. US regulation on AI is moving slowly—risk of heavier regulation remains but is not imminent within one year.</li>
<li><strong>Semiconductors</strong>: The US domestic chip sector continues rapid extension, with production growth well above 7% expected this year. Disruption risk focused at the intersection of trade (tariffs) and supply chain exposure (especially Taiwan and South Korea).</li>
</ul>
<h3>Energy &amp; Utilities</h3>
<ul>
<li><strong>Outlook</strong>: Despite climate goals, oil and coal are likely to remain dominant in the global energy mix through 2030. Near-term, US is not on track to meet climate targets, while India is; significant implications for energy exporters and industrials with US focus.</li>
<li><strong>Oil/Nat Gas</strong>: Oil faces substantial volatility from political risk and supply-side shocks. Near-term price drawdowns below $65 are widely anticipated, but unstable rebounds to $75–$90 are possible if geopolitical risks spark fear. Natural gas is expected to exhibit high price volatility, with substantial upside moves likely this year—watch for opportunities in spot or producers.</li>
<li><strong>Renewables</strong>: US solar installations continue robust growth but face headwinds from policy uncertainty and tariffs. Tesla’s energy division growth prospects are solid, but not likely to meet the most aggressive targets in the next year.</li>
</ul>
<h3>Financials</h3>
<ul>
<li><strong>Banking Leadership</strong>: Anticipated transition at JPMorgan with Marianne Lake emerging as a front-runner for CEO—potential impact on banking sector strategy and risk appetite.</li>
<li><strong>Fintech IPOs</strong>: Stripe, Klarna and Ramp are not expected to file imminently, with only Klarna showing some IPO momentum. Broader weakness and uncertainty remain in private fintech exits.</li>
</ul>
<h3>Healthcare &amp; Biotech</h3>
<ul>
<li><strong>Drug Approvals &amp; Legislation</strong>: FDA action on psychedelic-based treatments possible before 2027, providing speculative momentum. No near-term game-changers for Type 1 diabetes (&quot;cure&quot; approval before early 2030s unlikely).</li>
<li><strong>mRNA Policy Backlash</strong>: Cuts to federal mRNA research funding may have longer-term impacts on the vaccine pipeline and biotech innovation.</li>
</ul>
<h3>Industrials/Defense</h3>
<ul>
<li><strong>Defense Focus</strong>: No sign of rapid IPO pipeline for defense tech (e.g., Anduril not expected to file soon), but sector demand remains robust thanks to geopolitical tensions and tariff-related industrial policy.</li>
</ul>
<hr />
<h2>Asset-Specific Highlights</h2>
<h3>Equities</h3>
<ul>
<li><strong>Index Trends</strong>: No indication of imminent market circuit-breakers, recession, or severe sell-off. Concentration risk remains high in the “Magnificent 7,” especially as Nvidia’s top-spot dominance is increasingly probable and Apple recedes in relative market cap.</li>
<li><strong>Individual Names</strong>:
<ul>
<li><strong>Nvidia</strong>: On track to be the largest global company by market cap at year-end, reflecting AI/semiconductor tailwinds.</li>
<li><strong>Microsoft</strong>: Strong AI integration, but less likely to regain the #1 market cap spot.</li>
<li><strong>Apple</strong>: Slipping out of the lead, lagging both in excitement and valuation versus peers.</li>
<li><strong>Tesla</strong>: Energy storage and renewables units growing yet face realistic, not hyperbolic, ramp.</li>
</ul>
</li>
</ul>
<h3>Crypto/Digital Assets</h3>
<ul>
<li><strong>Bitcoin</strong>: Expected to maintain high values, with growing probability of surpassing $130K within the next 16 months, although the $250K &quot;hyperbull&quot; scenario is still considered a long shot.</li>
<li><strong>Ethereum</strong>: $5K target plausible this year, rapid moves possible but extreme upside less likely.</li>
<li><strong>Stablecoins</strong>: Tether depeg and insolvency risks remain low in the near term.</li>
<li><strong>Crypto ETFs</strong>: Approval pipeline active (Ripple, Doge ETFs very likely to clear soon); will further institutionalize crypto adoption.</li>
</ul>
<h3>Commodities</h3>
<ul>
<li><strong>Metals</strong>: Tariff escalation (e.g., copper) highly probable, directing flows into non-US and &quot;onshore&quot; supply.</li>
<li><strong>Oil/Nat Gas</strong>: Both remain volatile and sensitive to macro/geopolitics, with risk skewed to upside for natural gas and high tail risk for oil if diplomacy collapses.</li>
</ul>
<h3>Real Assets/REITs</h3>
<ul>
<li><strong>Natural Disaster Risks</strong>: Moderate odds of large earthquake events in California or Japan before 2030. Insurance and REITs with concentrated exposure in those locations should be stress-tested for event risk.</li>
</ul>
<hr />
<h2>Summary Thesis</h2>
<ul>
<li>The US enters late summer 2025 with growing protectionist leanings, a decelerating but positive economy, and persistent inflation—but not at crisis levels.</li>
<li>AI/tech consolidation continues, with regulatory risks building slowly in the background.</li>
<li>Aggressive US tariffs and global political jockeying risk reigniting input and consumer price pressure, while weighing on certain growth stocks and multinational exporters.</li>
<li>Defensive positioning in energy, select tech, and US-centric industrials likely to outperform, while hypergrowth private company IPO pipelines remain mostly frozen.</li>
<li>Crypto institutionalization accelerates under more favorable regulation, despite government spending/dollar debasement risks.</li>
<li>Cautious optimism for broad indices is warranted, but with close eye on FX instability, geopolitics, and US policy shocks. Continue to hedge, as tail risks (global recession, market circuit breakers, natural disasters) remain relevant but not central base cases.</li>
</ul>

</main>
</body>
</html>
